However, patients who receive prophylactic treatment still are at risk for bleeding events and chronic arthropathies, according to study background ... cost-effective analysis to derive a ...

A semi-Markov cost-effectiveness model (CEM) was developed with a 4-week cycle and 10-year analysis time horizon ... and no-treatment arms. Only background mortality was modeled.

Background: Despite statin therapy and ... Conclusion: In this combined patient-level and simulation cost-effectiveness analysis, icosapent ethyl in high CV risk patients shows exceptional benefit ...

A cost-effectiveness analysis comparing direct oral anticoagulants (DOACs) to low-molecular-weight heparin (LMWH) found that DOACs are both more medically effective and cost-effective than LMWH ...

Iron deficiency — the most common micronutrient deficiency — is one of the top five causes worldwide of years lived with disability, according to study background. The condition ...

A consultation from the National Institute for Health and Care Excellence (NICE) and NHS England (NHSE) has proposed what amounts to an explicit, third threshold for cost-effectiveness to be used ...

In a peer-reviewed article just published in the journal Health Affairs, Atheendar Venkataramani, Dean Schillinger, and I make the case that standard approaches to cost-effectiveness analysis in ...

This analysis examines the cost effectiveness of the ingredients necessary and cost per person and cost per outcome achieved from a six-day governance leadership training course in Zimbabwe.

The Best Use of Resources team focuses on informing decision making on efficiency and effectiveness. The IRC uses the ingredients methodology to conduct cost analysis (Levin and McEwan, 2001). IRC’s ...

Drawing on her background as a founder of multiple startups, she writes for Forbes Advisor SMB on topics including business formation... Lauren (Hansen) Holznienkemper is a lead editor for the ...